Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck Bets Moderna's Cancer Vaccines Can Prime Patients For Immunotherapy

Jun 29 2016

• By Joseph Haas

business

Related Content

AstraZeneca Ups Betting Ante On Moderna's Messenger RNA Technology

Jan 12 2016

VC Roundup: Annexon, Mersana Benefit As Investors Favor Private Over Public Biotechs

Jun 25 2016

Moderna raises $450m; most ever for private biotech

Jan 06 2015

Merck moves into mRNA space with Moderna alliance

Jan 14 2015

Related Companies

Merck & Co., Inc.

Moderna, Inc.

SELLAS Life Sciences Group, Inc.

AstraZeneca PLC

Additional Topics

Companies Deals Cancer

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window